The Ohio State University Comprehensive Cancer Center, Richard J. Solove Research Institute, and James Cancer Hospital have discovered a new molecular therapeutic target that could lead to the development of new cancer treatments with fewer side effects. Previous research has revealed that VEGF-A, a powerful cytokine (signalling protein), and dopamine, a neurotransmitter/neurohormone, play critical roles […]

The post New Molecular Target For Cancer Therapy Found Through Study first appeared on World Pharma Today.